WeVote

Bill

Bill

HB 6817

AN ACT REQUIRING THE INSURANCE DEPARTMENT TO STUDY HEALTH CARRIER USE OF PRIOR AUTHORIZATIONS.

2025 Regular Session Introduced by Jonathan Steinberg

HB 6817 directs the Insurance Department to study how health carriers use prior authorizations and how this affects patients, providers, and access to care.

REF. TO JOINT COMM. ON Insurance and Real Estate
0
WeVote Research Nonpartisan
Bill Summary · HB 6817

HB 6817 — Summary

Title and Basic Information

  • Bill Number: HB 6817
  • Official Title: AN ACT REQUIRING THE INSURANCE DEPARTMENT TO STUDY HEALTH CARRIER USE OF PRIOR AUTHORIZATIONS
  • Status: Ref. to Joint Committee on Insurance and Real Estate
  • Introduced: January 29, 2025
  • Classification/Subject: Bill; subjects include Fines (Penalties), Health Insurance, Insurance Department, Studies

Purpose and Intent

  • The bill directs the Insurance Department to study how health carriers (insurers) use prior authorizations for medical services, treatments, or procedures. The stated objective is to assess and understand prior authorization practices within health insurance.

Key Provisions (as implied by the title)

  • Require the Insurance Department to conduct a study on:
    • How health carriers implement and use prior authorization processes
    • Potential impacts on patients, providers, and access to care
  • The bill would likely establish mechanisms related to the study (e.g., scope, methodology, reporting), though specific details such as scope, metrics, reporting deadlines, and any penalties are not provided in the available information.
  • No explicit text on fines, penalties, or enforcement is included in the provided summary, though the bill’s subject area lists “Fines (Penalties)” among its topics.

Affected Parties

  • State Insurance Department: Responsible for conducting the study and reporting findings.
  • Health Carriers / Health Insurers: Subject of the study and potential changes to practices depending on findings.
  • Healthcare Providers: Affected by prior authorization processes and potential recommendations for improvement.
  • Patients/Consumers: Could benefit from insights into delays or barriers caused by prior authorizations and any recommended reforms.

Procedural and Timeline Aspects

  • Introduced: January 29, 2025
  • Current Action: Ref. (referral) to the Joint Committee on Insurance and Real Estate
  • Next Steps: Typically, the committee would hold hearings, possibly amend, and vote before advancing to the full chamber. The absence of a specified reporting deadline or milestones means timelines would be determined during committee consideration.

Notes

  • Details on the study’s scope, deliverables (e.g., final report contents), timeline, and any associated penalties are not provided in the available information. This summary reflects the bill’s stated objective and current procedural status based on the provided text.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.